Westlake Lingxi Raises Strategic Round from Huichuang Medical for BCI Chips
Westlake Lingxi closed a strategic round from Huichuang Medical to build next-gen BCI infrastructure—neuromorphic chips, compute architecture and decoding algorithms—plus system validation. Related: Zhentai BCI round.
© 版权声明
The copyright of the article belongs to the author, please do not reprint without permission.
相关文章
AI Navigation collects the latest AI news and tools. Follow us and never get lost in the AI world.